Cost and cost effectiveness of Herpes simplex virus-type 2 (hsv-2) suppressive therapy in HIV-1 and HSV-2 infected women in Johannesburg, South Africa

Devine, A; Meyer-Rath, G; Foss, A; Vickerman, P; Edwards, M; Bachmann, M; Mayaud, P; Delany-Moretlwe, S; (2009) Cost and cost effectiveness of Herpes simplex virus-type 2 (hsv-2) suppressive therapy in HIV-1 and HSV-2 infected women in Johannesburg, South Africa. [Conference or Workshop Item] http://researchonline.lshtm.ac.uk/id/eprint/5470

Permanent Identifier

Use this permanent URL when citing or linking to this resource.

http://researchonline.lshtm.ac.uk/id/eprint/5470

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Google Scholar